drug
bromocriptine mesylate
Marketedupdated 3mo agoby Validus Pharmaceuticals LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2indications
investigational
Parkinson's DiseaseType 2 Diabetes
all catalysts(0)
nothing on the calendar yet
Trials studying bromocriptine mesylate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 7, 2030
~3.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (13)
- Apr 30, 2032method-of-use (U-2886)US 10688094
- Apr 30, 2032method-of-use (U-3122)US 11000522
- Apr 30, 2032method-of-use (U-4018)US 11666567
- Apr 30, 2032formulationUS 8431155
- Apr 30, 2032formulationUS 8613947
- Apr 30, 2032formulationUS 9192576
- Apr 30, 2032formulationUS 9522117
- Apr 30, 2032formulationUS 9700555
- Apr 30, 2032method-of-use (U-2389)US 9993474
- Jun 7, 2030method-of-use (U-2934)US 106881553.8y
- Jun 7, 2030formulationUS 88777083.8y
- Jun 7, 2030method-of-use (U-2116)US 93520253.8y
- Jun 7, 2030method-of-use (U-2283)US 98954223.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 24m ago
Found something off?
comments(0)
5-min edit window · permanent after that